Schedule of Reconciliation of Weighted Average Shares Outstanding (Details) - USD ($)	3 Months Ended						9 Months Ended
	Oct. 31, 2024	Jul. 31, 2024	Apr. 30, 2024	Oct. 31, 2023	Jul. 31, 2023	Apr. 30, 2023	Oct. 31, 2024	Oct. 31, 2023
Accounting Policies [Abstract]
Net income ( loss)	$ 926,992	$ 1,149,145	$ 311,381	$ (252,609)	$ (203,379)	$ (118,579)	$ 2,387,518	$ (574,567)
Derivative (gain) loss associated with convertible debt	(11,432)						(14,876)
Interest expense associated with convertible debt	(5,142)						(16,415)
Net income (loss) for dilutive calculation	$ 910,418			$ (252,609)			$ 2,356,227	$ (574,567)
Weighted average common shares outstanding	50,794,090			32,289,211			50,193,594	24,676,301
Dilutive effect of convertible debt
Dilutive effect of common stock warrants	9,281,827						10,412,006
Dilutive effect of common stock options	1,525,386						1,743,667
Weighted average shares outstanding for diluted net income (loss) per share	61,601,303			32,289,211			62,349,267	24,676,301